Listen on Apple Podcasts, Google Podcasts, Overcast, Spotify, Stitcher, Vimeo, YouTube.
What has contributed to the biotechnology industry’s explosive growth over the last several years? In this episode, special guests Don and Lisa Drakeman, two former CEOs of biotech companies, reflect on what it takes to succeed, the regulatory challenges they have faced, and how current events are shaping the future of the industry.
Joining our special guests are Epstein Becker Green attorneys Robert Wanerman and Rachel Weisblatt, who address how biotech leaders, entrepreneurs, and investors can best navigate the complex legal issues that arise along the path from product development to thriving business.
For more from today’s special guests, visit: https://www.thebusinessofbiotechnology.com/
About the Diagnosing Health Care Podcast
The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.
Trouble listening to this podcast? Please contact us at email@example.com and mention whether you were at home or working within a corporate network. We’d also love to hear your suggestions for future episode topics.
Subscribe to the Podcast
Never miss an episode! Subscribe to Diagnosing Health Care on your preferred platform – Amazon Music / Audible, Apple Podcasts, Audacy, Deezer, Google Podcasts, iHeartRadio, Overcast, PlayerFM, Spotify, Stitcher, Vimeo, YouTube.
Spread the Word
Would your colleagues, professional network, or friends benefit from Diagnosing Health Care? Please share the edition each week on LinkedIn, Facebook, YouTube, Instagram, and Twitter, and your connections can subscribe for email notifications.